Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results.

Xieer Liang,Zhiliang Gao,Qing Xie,Jiming Zhang,Jifang Sheng,Jun Cheng,Chengwei Chen,Qing Mao,Wei Zhao,Hong Ren,Deming Tan,Junqi Niu,Shijun Chen,Chen Pan,Hong Tang,Hao Wang,Yimin Mao,Jidong Jia,Qin Ning,Min Xu,Shanming Wu,Jun Li,Xinxin Zhang,Wenyan Zhang,Cui Xiong,Jinlin Hou

Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results.

2019

Background and aim Long-term treatment with tenofovir disoproxil fumarate (TDF) has demonstrated suppression of viral replication outside of China. This study aims to assess efficacy, resistance and safety of TDF for up to 240 weeks in Chinese patients with chronic hepatitis B virus (HBV) infection.

Keywords:

Hepatitis B
Viral replication
Tenofovir
Virology
Diabetes mellitus
Medicine
Hepatitis B virus
Creatinine
Adefovir
Gastroenterology
Internal medicine
HBsAg
Adverse effect
HBeAg
Hepatology
Clinical trial
Alanine transaminase

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations